Exogenous Hormone Therapy refers to the administration of hormones that originate from an external source, such as pharmaceutical preparations, rather than being naturally produced by the patient’s own endocrine glands. This clinical intervention is used to correct hormonal deficiencies, manage symptoms related to endocrine decline, or suppress endogenous hormone production for specific therapeutic goals. The compounds can be bioidentical or synthetic in their molecular structure.
Origin
The term combines “exogenous,” derived from the Greek exo- (outside) and genes (producing), with “hormone therapy,” the treatment of disease or symptoms with hormones. This terminology is necessary to distinguish administered hormones from the body’s endogenous (internally produced) hormones. It clearly defines the source of the therapeutic agent, which has implications for pharmacokinetics and monitoring.
Mechanism
The mechanism involves the externally supplied hormone molecules circulating in the bloodstream and binding to the patient’s native, intracellular or cell-surface hormone receptors. This binding event initiates a downstream signaling cascade, effectively mimicking or augmenting the action of the deficient or suppressed endogenous hormone. Precise dosing is crucial to achieve therapeutic effects while avoiding supraphysiological levels that could lead to negative feedback loops or adverse side effects on the hypothalamic-pituitary axis.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.